Article
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies.
Genetics in medicine : official journal of the American College of Medical Genetics - 1 Jan 2021
Roloff Gregory W, Godley Lucy A, Drazer Michael W
Abstract excerpt
PURPOSE: To determine the degree of testing consistency among commercially available diagnostic assays for hereditary hematopoietic malignancies (HHMs). METHODS: Next-generation sequencing assays designed for the diagnosis of HHMs were studied to determine which genes were sequenced, their ability to detect variant types relevant for HHMs, and clinical-grade characteristics such as price, turnaround time, and...
Topics
Join the communities discussing this publication.
